Dalton Pharma Services has entered into a manufacturing services agreement with Zafgen, Inc. to provide cGMP aseptic fill/finish services and analytical support for Zafgen’s lead obesity treatment. “Adding Zafgen to our growing list of strategic relationships with innovative pharmaceutical clients is an important milestone for Dalton,” said Peter Pekos, Dalton Pharma’s president and chief executive officer. “We are thrilled to be working with the Zafgen team and look forward to a successful c...